1. Abdel-Rahman, M., Jackson, L., Rodewald, K., Abdellah, M., Ismail, S., & Hurd, W. (2012). Polycystic ovary syndrome and diabetes screening: a survey of gynecologists and reproductive endocrinologists. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 162(2), 178–181.
2. ACOG. (2008). ACOG committee opinion No. 413: age-related fertility decline. Obstetrics and Gynecology, 112, 409–411.
3. Ambry Genetics. (2013). The case for clinical adoption of hereditary breast cancer panel testing. http://www.ambrygen.com/sites/default/files/BreastNext_WhitePaper_112812_0.pdf : Ambry Genetics.
4. American Cancer Society. (2013). Cancer facts & figures 2013. Atlanta: American Cancer Society.
5. Berliner, J. L., Fay, A. M., Cummings, S. A., Burnett, B., & Tillmanns, T. (2013). NSGC practice guidelines: risk assessment and genetic counseling for hereditary breast and ovarian cancer. Journal of Genetic Counseling, 22, 155–163.